Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
Desai H, Aronow WS, Tsai FS, Ahn C, Lai HM, Amin H, Gandhi K, Frishman WH, Cohen M, Sorbera C. Desai H, et al. Among authors: lai hm. J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):176-9. doi: 10.1177/1074248409340157. Epub 2009 Jul 17. J Cardiovasc Pharmacol Ther. 2009. PMID: 19617418
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.
Desai H, Aronow WS, Ahn C, Tsai FS, Lai HM, Gandhi K, Amin H, Frishman WH, Kalapatapu K, Cohen M, Sorbera C. Desai H, et al. Among authors: lai hm. J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):37-40. doi: 10.1177/1074248409351408. Epub 2009 Dec 4. J Cardiovasc Pharmacol Ther. 2010. PMID: 19966176
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up.
Gandhi K, Aronow WS, Desai H, Amin H, Lai HM, Frishman WH, Cohen M, Sorbera C. Gandhi K, et al. Among authors: lai hm. Arch Med Sci. 2010 Dec;6(6):900-3. doi: 10.5114/aoms.2010.19299. Epub 2010 Dec 29. Arch Med Sci. 2010. PMID: 22427764 Free PMC article.
185 results